Skip to content
healthcare.dev

Sucralfate

NDC 81033-149, Sucralfate, suspension, from Kesin Pharma Corporation.

Product NDC
81033-149
Status
Listed
Labeler
Kesin Pharma Corporation
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216474
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81033-149 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUCRALFATE1 g/10mL

Pharmacologic classes

Aluminum Complex [EPC]; Organometallic Compounds [CS]

Package NDCNDC-11Package
81033-149-448103301494440 CUP, UNIT-DOSE in 1 CARTON (81033-149-44) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10)
81033-149-5281033014952100 CUP, UNIT-DOSE in 1 CASE (81033-149-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-149-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36d940f2-207b-68c5-e063-6294a90a6b4a

Use it

Look up 81033-149 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81033-149 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81033-149. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.